NCT03155061 2025-06-05Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid TumorsOno Pharmaceutical Co. LtdPhase 1 Active not recruiting183 enrolled
NCT01928394 2024-12-27A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid TumorsBristol-Myers SquibbPhase 1/2 Completed1,163 enrolled 33 charts 1 FDA
NCT03730337 2023-10-04Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid TumorsOno Pharmaceutical Co. LtdPhase 1 Completed24 enrolled